Biopharmaceutical Research
Pharmaceutical manufacturing and analytical firm focused on the production of cannabis for researchers across the United States and the USDA-compliant THC testing of hemp.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $20.0m Valuation: $116m | Series A | |
| Total Funding | 000k | ||
Related Content
Biopharma Research Co. (BRC) is a fully integrated, federally legal cannabis research, development, and production company. Operating within the pharmaceutical sector, BRC specializes in developing federally compliant active pharmaceutical ingredients (APIs) for plant-based therapeutics. The company serves a diverse range of clients including researchers, academic institutions, and DEA registrants across nearly a dozen states. BRC's mission is to deliver uncompromising quality in its products, which are produced in an indoor, cGMP compliant facility located in a highly secure area within an underserved community in the United States. The company supports Investigational New Drug (IND) applications for researchers focused on treatments for PTSD, chronic pain, and other conditions. BRC generates revenue through the sale of its high-quality APIs to various stakeholders in the pharmaceutical and research sectors.
Keywords: cannabis, research, development, production, pharmaceutical, APIs, therapeutics, DEA compliant, IND applications, PTSD, chronic pain.